Bavarian Nordic A/S

Bavarian Nordic A/S

BVNRY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.8B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bavarian Nordic A/SBavarian Nordic A/S12-7%0.5-

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.80 Billion
Enterprise Value$1.77 Billion
Earnings per Share$5.66
Beta0.94
Outstanding Shares227,883,789

Return

Return on Equity6.76%ROE
Return on Assets6.06%
Return on Invested Capital8.35%

Valuation & Multiples

P/E Ratio12.02P/E Ratio
PEG-20.34PEG
Price to Sales0.46Price to Sales
Price to Book Ratio0.2Price to Book Ratio
Enterprise Value to Revenue0.29
Enterprise Value to EBIT1.52
Enterprise Value to Net Income1
Total Debt to Enterprise0.07
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 13, 2026
EPS
$0.28
Reported
Revenue
$266.15 M
Est. $198.31 M

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Bavarian Nordic A/S

1,906 employees
CEO: Paul John Chaplin

Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for sm...

Questions & Answers